Diamonds and Dogs
Genetic Technologies Limited (GENE)
Genetic Technologies is soaring today, up 27.19% to $5.38. The genetic testing company saw its shares spike after announcing its two new breast health centers will start to offer BREVAGenplus, which is a scientifically validated risk test for sporadic breast cancer. Genetic Technologies said it expects more breast health centers to adopt BREVAGenplus in 2015 and reiterates its expectations for accelerated sales growth in the second half of 2015 and beyond. Shares of Genetic Technologies climbed over $1.00 today but are still well off of their 52-week high of $11.00.
Ampio Pharmaceuticals Inc. (AMPE)
Ampio Pharmaceuticals is getting demolished today, down 65.31% to $2.73. The biopharmaceutical company saw its shares tank after announcing that the multiple injection STRIDE study AP008 did not reach its primary endpoint against the saline control even though there was a statistically significant reduction in pain compared to baseline for patients receiving Ampion. Shares of Ampio fell over $5.00 today and hit a new 52-week low of $2.49 intraday.